Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rapid Response of Stem Cells and Immune Cells for Efficacy: An Acute Randomized Double-blind Placebo-controlled Cross-over Trial

NCT07127705 is registered in ClinicalTrials.gov with Natural Immune Systems Inc as lead sponsor.

NCT NCT07127705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07127705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rapid Response of Stem Cells and Immune Cells for Efficacy: An Acute Randomized Double-blind Placebo-controlled Cross-over Trial
Lead sponsor
Natural Immune Systems Inc
Phase
Not applicable
Overall status
Recruiting
Start date
May 21, 2025
Completion date
October 3, 2025
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stem cell surveillance